PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Beyond Diuretic Titration: AI-Adapted Pulmonary Artery Pressure Monitoring in Heart Failure

heart failurepulmonary artery pressure monitoringimplanted hemodynamic monitoringremote patient managementartificial intelligenceCardioMEMSCHAMPIONGUIDE-HFMONITOR-HFPASSPORT-HFnarrative reviewGDMTdiuretics Cardiology

Background Information

AI-driven heart failure monitoring may redefine patient management.

Implanted pulmonary artery pressure monitoring aids in early detection of worsening heart failure, potentially reducing hospitalizations. Pulmonary artery pressure-guided management effectively lowers heart failure hospitalizations, but additional risk persists; AI could further enhance outcomes. AI-based personalized patient management may optimize monitoring and treatment in heart failure, but this concept is not yet clinical practice. AI could personalize heart failure management by modeling individual risks and optimizing monitoring.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Angermann CE, Asselbergs FW, Ertl G, Störk S

Citation: Angermann CE, Asselbergs FW, Ertl G, et al. Personalized Remote Patient Management in Heart Failure : From Implanted Hemodynamic Monitoring Toward an Artificial Intelligence-Supported Adaptive Care Cycle. Current heart failure reports. 2026;23(1). doi:10.1007/s11897-026-00783-8

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.